Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F FROMM

Showing results (151-160 of 247) with videos related to

Pageof 25
Sort By:
Deutsches Arzteblatt International|July 22, 2025
Pseudo-Worsening of Kidney FunctionMartin F Fromm, Michael I Sponfeldner, Frank Dörje, et al.
Clinical Pharmacology and Therapeutics|May 29, 2009
ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatinJ E Keskitalo, O Zolk, M F Fromm, et al.
Clinical Pharmacology and Therapeutics|August 16, 2024
New Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in HumansArne Gessner, Jörg König, Pia Wenisch, et al.
Clinical Pharmacology and Therapeutics|August 4, 2023
A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter-Mediated Drug-Drug InteractionsArne Gessner, Fabian Müller, Pia Wenisch, et al.
British Journal of Clinical Pharmacology|May 8, 2002
MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadineSiegfried Drescher, Elke Schaeffeler, Monika Hitzl, et al.
Molecular Pharmacology|June 7, 2011
Functional and structural relevance of conserved positively charged lysine residues in organic anion transporting polypeptide 1B3Kathrin Mandery, Heinrich Sticht, Krystyna Bujok, et al.
Circulation. Cardiovascular Genetics|June 21, 2011
Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placementDietmar Trenk, Willibald Hochholzer, Martin F Fromm, et al.
The American Journal of Pathology|November 10, 2012
Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanismsOliver Zolk, Rebecca Schnepf, Marc Muschler, et al.
Plos One|October 2, 2015
Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-GlycoproteinJana Knop, Shingen Misaka, Katrin Singer, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 25, 2000
Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoproteinC Pauli-Magnus, O von Richter, O Burk, et al.
Pageof 25

Showing results (151-160 of 247) with videos related to

Sort By:
Pageof 25
Deutsches Arzteblatt International|July 22, 2025
Pseudo-Worsening of Kidney FunctionMartin F Fromm, Michael I Sponfeldner, Frank Dörje, et al.
Clinical Pharmacology and Therapeutics|May 29, 2009
ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatinJ E Keskitalo, O Zolk, M F Fromm, et al.
Clinical Pharmacology and Therapeutics|August 16, 2024
New Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in HumansArne Gessner, Jörg König, Pia Wenisch, et al.
Clinical Pharmacology and Therapeutics|August 4, 2023
A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter-Mediated Drug-Drug InteractionsArne Gessner, Fabian Müller, Pia Wenisch, et al.
British Journal of Clinical Pharmacology|May 8, 2002
MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadineSiegfried Drescher, Elke Schaeffeler, Monika Hitzl, et al.
Molecular Pharmacology|June 7, 2011
Functional and structural relevance of conserved positively charged lysine residues in organic anion transporting polypeptide 1B3Kathrin Mandery, Heinrich Sticht, Krystyna Bujok, et al.
Circulation. Cardiovascular Genetics|June 21, 2011
Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placementDietmar Trenk, Willibald Hochholzer, Martin F Fromm, et al.
The American Journal of Pathology|November 10, 2012
Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanismsOliver Zolk, Rebecca Schnepf, Marc Muschler, et al.
Plos One|October 2, 2015
Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-GlycoproteinJana Knop, Shingen Misaka, Katrin Singer, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 25, 2000
Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoproteinC Pauli-Magnus, O von Richter, O Burk, et al.
Pageof 25